AUTHOR=Zhai Junyu , Li Shang , Sen Sushmita , Opoku-Anane Jessica , Du Yanzhi , Chen Zi-Jiang , Giudice Linda C. 

TITLE=m6A RNA Methylation Regulators Contribute to Eutopic Endometrium and Myometrium Dysfunction in Adenomyosis

JOURNAL=Frontiers in Genetics

VOLUME=11

YEAR=2020

URL=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.00716

DOI=10.3389/fgene.2020.00716

ISSN=1664-8021

ABSTRACT=<p>Adenomyosis is a prevalent, estrogen-dependent uterine disorder wherein endometrial cells are abnormally present in the myometrium and are surrounded by hyperplastic/hypertrophic smooth muscle. Its etiology is unclear, although endometrial cell invasion into the myometrium has been postulated. RNA methylation, particularly N6-methyladenosine (m<sup>6</sup>A), plays an important role in regulating various physiological processes and invasive disorders. The goal of this <italic>in silico</italic> and lab-based experimental study was to explore a possible role for m<sup>6</sup>A in adenomyosis. Gene expression profiles of both the endometrium and myometrium of women with adenomyosis (cases) and without disease (controls) were obtained from the publicly available Gene Expression Omnibus (GEO) database. In the endometrium, STRING database analysis revealed that <italic>METTL3</italic> functions as a “hub” gene of m<sup>6</sup>A RNA methylation regulators, and the genes involved in m<sup>6</sup>A regulation, including <italic>METTL3</italic>, <italic>FTO</italic>, <italic>ZC3H13</italic>, and <italic>YTHDC1</italic> expression, were significantly decreased in cases versus controls. Functional, co-expression, and correlational analyses of endometrium from cases versus controls revealed decreased total m<sup>6</sup>A levels, induced by <italic>METTL3</italic>, and the downstream elevated <italic>insulin−like growth factor−1(IGF1)</italic> and <italic>D-Dopachrome Tautomerase</italic> (<italic>DDT)</italic>, with the latter two having known functions in epithelial proliferation and cell migration, which are important processes in the pathogenesis of adenomyosis in endometrium. m<sup>6</sup>A RNA methylation regulators, including <italic>RBM15/15B</italic>, <italic>ALKBH5</italic>, <italic>FTO</italic>, <italic>YTHDF1/2</italic>, <italic>KIAA1429</italic>, <italic>HNRNPC</italic>, <italic>METTL3</italic>, <italic>ZC3H13</italic>, and <italic>YTHDC2</italic>, were also differentially expressed in the myometrium from cases versus controls. We validated decreased total m<sup>6</sup>A levels and differential expression of m<sup>6</sup>A RNA methylation regulators in the myometrium of patients with adenomyosis using qRT-PCR, immunohistochemistry and tissues available from our biorepository. Possible target genes, including <italic>cadherin 3(CDH3)</italic>, <italic>sodium channel</italic>β<italic>-subunit 4</italic> (<italic>SCN4B)</italic>, and <italic>placenta-specific protein 8 (PLAC8)</italic>, which are involved in cell adhesion, muscle contraction and immune response in the myometrium of adenomyosis patients were also validated. Thus, through extensive public database mining and validation of select genes, this study, for the first time, implicates m<sup>6</sup>A and its methylation regulators in the pathogenesis of adenomyosis. Follow on functional studies are anticipated to elucidate mechanisms involving m<sup>6</sup>A and its regulators and down-stream effectors in the pathogenesis of this enigmatic reproductive disorder and potentially identify druggable targets to control its associated symptoms.</p>